Actively Recruiting

Phase 2
Age: 60Years - 95Years
All Genders
Healthy Volunteers
NCT04765137

Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)

Led by Johns Hopkins University · Updated on 2025-08-06

20

Participants Needed

1

Research Sites

292 weeks

Total Duration

On this page

Sponsors

J

Johns Hopkins University

Lead Sponsor

T

The Richman Family Precision Medicine Center of Excellence in Alzheimer Disease

Collaborating Sponsor

AI-Summary

What this Trial Is About

The purpose of this study is to evaluate the effect of atorvastatin on brain vessel reactivity and with it on blood flow in people with mild cognitive impairment.

CONDITIONS

Official Title

Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI)

Who Can Participate

Age: 60Years - 95Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Diagnosis of mild cognitive impairment (MCI) with Clinical Dementia Rating of 0.5 or 1.0
  • Cognitive scores more than 1.5 standard deviations below age-education norms in memory, processing speed, executive function, or language
  • No history of dementia
  • Not currently taking statins or taken statins in the last 6 months
  • Cognitive or functional impairment not due to another neurological disease or delirium
Not Eligible

You will not qualify if you...

  • Currently taking statins or have taken statins in the last 6 months
  • Contraindications to taking statins
  • Transplant patients taking cyclosporine
  • Unable to undergo MRI due to incompatible implants or metal
  • Diagnosis of dementia by history
  • Current substance abuse diagnosis
  • Stroke or myocardial infarction within the past 6 months
  • History of HIV infection

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Johns Hopkins University, Bayview Medical Center

Baltimore, Maryland, United States, 21224

Actively Recruiting

Loading map...

Research Team

S

Samantha Horn

CONTACT

R

Ritu Agarwal

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in Mild Cognitive Impairment (MCI) | DecenTrialz